Onderneming Kindstar Globalgene Technology, Inc.
Aandelen
9960
KYG5262E1044
Gezondheidszorgvoorzieningen & -diensten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,53 HKD | 0,00% | +2,68% | -8,93% |
27/03 | Kindstar Globalgene Technology, Inc. rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
2023 | Kindstar Globalgene boekt 31% minder inkomsten in H1 | MT |
Vakgebied
Aantal werknemers: 3 125
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
COVID-19 Related Testing
38,7
%
| 75 | 6,7 % | 624 | 38,7 % | +733,72% |
Hematology Testing
37,9
%
| 645 | 57,5 % | 611 | 37,9 % | -5,22% |
Neurology
6,9
%
| 108 | 9,7 % | 111 | 6,9 % | +2,40% |
Routine Testing
4,1
%
| 82 | 7,3 % | 67 | 4,1 % | -18,10% |
Maternity-related Diseases
3,6
%
| 63 | 5,6 % | 58 | 3,6 % | -7,74% |
Infectious Diseases
3,4
%
| 63 | 5,6 % | 55 | 3,4 % | -11,45% |
Genetic Diseases and Rare Diseases
3,1
%
| 52 | 4,7 % | 50 | 3,1 % | -5,10% |
Oncology
1,3
%
| 10 | 0,9 % | 21 | 1,3 % | +100,17% |
Others
0,9
%
| 23 | 2,1 % | 15 | 0,9 % | -35,16% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 1 122 | 100,0 % | 1 612 | 100,0 % | +43,75% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 22-02-11 |
Hai Jie Chai
DFI | Director of Finance/CFO | 46 | 04-12-20 |
Zan Bing Tu
COO | Chief Operating Officer | 52 | 04-12-20 |
Mei Yi Lee
SEC | Corporate Secretary | 56 | 15-08-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Zuie Chin Huang
BRD | Director/Board Member | 58 | 30-01-12 |
Xin Ping Xia
BRD | Director/Board Member | 59 | 23-02-21 |
Shi Ang Huang
CEO | Chief Executive Officer | 66 | 22-02-11 |
Zan Bing Tu
COO | Chief Operating Officer | 52 | 04-12-20 |
Lu Huang
BRD | Director/Board Member | 51 | 09-09-20 |
Hua Ming Gu
BRD | Director/Board Member | 60 | 23-02-21 |
Hai Jie Chai
DFI | Director of Finance/CFO | 46 | 04-12-20 |
Wei Peng
BRD | Director/Board Member | 38 | 27-10-20 |
Shang Long Yao
BRD | Director/Board Member | 68 | 23-02-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 019 125 696 | 541 426 540 ( 53,13 %) | 32 003 000 ( 3,140 %) | 53,13 % |
Bedrijfsgegevens
Kindstar Globalgene Technology, Inc.
East Lake High Tech Zone 666 Gaoxin Road
430075, Wuhan
+
http://www.kindstar.com.cnSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,93% | 186 mln. | |
-19,23% | 8,01 mld. | |
+37,47% | 3,52 mld. | |
-26,35% | 2,98 mld. | |
-7,18% | 2,48 mld. | |
-11,41% | 2,31 mld. | |
-15,45% | 1,75 mld. | |
-23,06% | 1,45 mld. | |
-38,05% | 1,27 mld. | |
-7,98% | 1,08 mld. |
- Beurs
- Aandelen
- Koers 9960
- Onderneming Kindstar Globalgene Technology, Inc.